| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156451C Betz 2-adrenoceptor agonists |
| 07/07/2004 | CN1156449C Process for preparing N-(amino-4,6-dihalopyrimidine) formamide |
| 07/07/2004 | CN1156448C Optical isomer of 3-methyl fentanyl, derivant, synthesizing and its analgesic activity |
| 07/07/2004 | CN1156446C Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 07/07/2004 | CN1156445C Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |
| 07/07/2004 | CN1156305C Chinese-medical oinment for treating burn |
| 07/07/2004 | CN1156304C Medicine for external application for curing diseases of digestive tract, repersussion and stopping pain and its preparation method |
| 07/07/2004 | CN1156302C Ointment capable of quick sterilizing AIDS, veneral virus and spermatozoa and preparation process thereof |
| 07/07/2004 | CN1156293C Tea Leaf-seed ointment for treating scald and its preparing process |
| 07/07/2004 | CN1156287C Composite medicine for treating myocardosis |
| 07/07/2004 | CN1156285C Medical wine for treating rheumatism, rheumatoid disease and phperosteogeny |
| 07/07/2004 | CN1156281C Application of ginsenoside Rg2 in preparing medicine for cardio-and cerebro-vascular disease |
| 07/07/2004 | CN1156280C Application of dimethyl silicone oil for treating ulcer colonitis |
| 07/07/2004 | CN1156279C Mometasone furoate as nasal spray and its preparing process |
| 07/07/2004 | CN1156278C Lower toxicity and anti-inflammatory and anti-exuation pharmaceutical composition |
| 07/07/2004 | CN1156277C Rapidlly soluble drug composition |
| 07/07/2004 | CN1156276C New use of theaflavin |
| 07/07/2004 | CN1156275C Application of chuanliansu as specific p-type calcium passage blocker |
| 07/07/2004 | CN1156274C Medicinal ointment containing zinc conjugated linoleate and sodium humate |
| 07/07/2004 | CN1156270C Method for producing solid dosing forms |
| 07/06/2004 | USRE38551 Anticonvulsant enantiomeric amino acid derivatives |
| 07/06/2004 | US6759544 Antimicrobially active acesulfame complexes, process for their preparation and their use |
| 07/06/2004 | US6759538 Substituted diphenyl heterocycles useful for treating HCV infection |
| 07/06/2004 | US6759536 Genetic engineering; polyketides |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759534 Reacting benzofuran derivative with organolithium compound in presence of sulfur source; reacting with dichloropyridazine derivative, reacting with alkaline alkoxide in alkanol; reacting with mineral acid, oxidation |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759437 Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
| 07/06/2004 | US6759436 Clear micellized formulations of β-carotene and method of treating leukoplakia |
| 07/06/2004 | US6759435 Such as methyl-(1-(2-(1-phenyl-ethyl)-phenyl)-ethyl)-amine; serotonin reuptake inhibitors |
| 07/06/2004 | US6759434 Anti-infective compositions, methods and systems for treating disordered tissue |
| 07/06/2004 | US6759433 Acetamidobenzamide compounds for neurodegenerative disorders |
| 07/06/2004 | US6759432 Prevent denaturing of collagen |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759425 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759423 4-Hydroxyisothiazole compounds |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759421 Indoline compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/2004 | US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects |
| 07/06/2004 | US6759418 6-(((2s)-2-(alkoxycabonyl)-4,4-difluoropyrrolidinyl)methyl)-1, 2, 3.4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylate, or acid derivatives, useful for treating migraine, and dural protein extravasation |
| 07/06/2004 | US6759417 Vascular endothelial growth factor receptor tyrosine kinase inhibitors; such as 7-amino-6-(1h-benzimidazol-2-yl)-3,4-dihydro-5h-imidazo(4,5-b)pyridin-5-one |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759414 Aromatic amides |
| 07/06/2004 | US6759413 Use of cox-2 inhibitors as gastroprokinetics |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759408 Cyclic combination therapies and regimens utilizing substituted indoline derivative compounds which are antagonists of the progesterone receptor |
| 07/06/2004 | US6759406 Quaternary ammonium compounds |
| 07/06/2004 | US6759405 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 07/06/2004 | US6759404 Inhibiting gamma-secretase activity; treating diseases associated with beta-amyloid production, such as alzheimer's disease |
| 07/06/2004 | US6759403 Metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 07/06/2004 | US6759402 Cyclic felbamate derived compounds |
| 07/06/2004 | US6759400 Meiosis regulating compounds |
| 07/06/2004 | US6759399 Using such as gamma-lactone of 10-ethynyl-17-hydroxy-3-oxo-19-nor-17-pregna-4,9(11)-diene-21-carboxylic acid |
| 07/06/2004 | US6759398 Anti-inflammatory androstane derivative |
| 07/06/2004 | US6759397 Ginsenoside chemotherapy |
| 07/06/2004 | US6759396 Compositions based on a synergistic mixture of at least one VDR ligand and a retinoid |
| 07/06/2004 | US6759395 Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759210 Compositions and methods for the treatment and diagnosis of cardiovascular disease using fehd545 as a target |
| 07/06/2004 | US6759201 Method of identifying a neural progenitor cell by evaluating expression of daedalos |
| 07/06/2004 | US6759194 Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 07/06/2004 | US6759065 Extraction method, pharmaceutical composition and a cosmetic composition |
| 07/06/2004 | US6759064 Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer |
| 07/06/2004 | US6759063 Concurrent administering plant extract and drug |
| 07/06/2004 | US6759062 Composition and method for treating the effects of diseases and maladies |
| 07/06/2004 | US6759059 Fentanyl composition for the treatment of acute pain |
| 07/06/2004 | US6759058 Enteric-coated proliposomal formulations for poorly water soluble drugs |
| 07/06/2004 | US6759053 Racemic mixtures of n-(prop-2-ynyl)-2-aminophenylpropane, used for the prophylaxis of neurodegenerative disorders and as immunomodulators |
| 07/06/2004 | US6759051 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol |
| 07/06/2004 | US6759049 Pharmaceutical or dietetic mushroom-based compositions |
| 07/06/2004 | US6759045 Administering antibodies; anticancer agents |
| 07/06/2004 | US6759029 Aerosols |
| 07/06/2004 | US6758840 Drug delivery device |
| 07/06/2004 | CA2312206C Novel bicyclic derivatives of amino-pyrazinones, process for preparing them and pharmaceutical compositions containing them |
| 07/06/2004 | CA2303594C Compounds for treating and preventing diabetic complications |
| 07/06/2004 | CA2278759C Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 07/06/2004 | CA2243715C Method for reducing skin oils and grease |
| 07/06/2004 | CA2235902C Method for treating protozoal infections |
| 07/06/2004 | CA2217417C 9-n-ethenyl derivatives of 9(s)-erythromycylamine |
| 07/06/2004 | CA2140361C Composition and methods for decreasing muscle breakdown |
| 07/06/2004 | CA2119556C Substituted aryl- and heteroaryl-phenyloxazolidinones |
| 07/06/2004 | CA2088831C Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
| 07/06/2004 | CA2085201C New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/06/2004 | CA2071510C 2' modified oligonucleotides |
| 07/06/2004 | CA2060401C N-2-chlorobenzyl-2-oxo and n-2-chlorobenzyl-2, 2-dioxo-1,2,3-oxathiazolidine derivatives, their preparation and synthesis of thieno¬3,2-c|pyridine derivatives therefrom |
| 07/01/2004 | WO2004055186A1 Guanosine triphosphate-binding protein-coupled receptor |
| 07/01/2004 | WO2004055185A1 Novel protein and dna thereof |
| 07/01/2004 | WO2004055184A1 GLUCOSE AND/OR FRUCTOSE TRANSPORTER NaGLT1 AND ITS GENE |
| 07/01/2004 | WO2004055163A2 Substituted 1-benzoyl-3-cyano-pyrrolo[1,2-a]quinolines |
| 07/01/2004 | WO2004055154A2 Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness |
| 07/01/2004 | WO2004055039A1 Steroid compounds with anti-tumor activity |
| 07/01/2004 | WO2004055034A1 Polymorph |
| 07/01/2004 | WO2004055026A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 07/01/2004 | WO2004055022A1 Use of cyclolignans as inhibitors of igf-1 receptor for treatment of malignat diseases |
| 07/01/2004 | WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | WO2004054999A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 07/01/2004 | WO2004054992A1 Novel retinol derivative and cosmetic composition comprising the same |